Corrigendum to "GFRα2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer" [Cancer Lett. 380 (2) (2016 Oct 1) 434-41
Errataetall: |
ErratumFor: Cancer Lett. 2016 Oct 1;380(2):434-41. - PMID 27400681 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:452 |
---|---|
Enthalten in: |
Cancer letters - 452(2019) vom: 28. Juni, Seite 270 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Gu, Jiangning [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 20.11.2019 published: Print-Electronic ErratumFor: Cancer Lett. 2016 Oct 1;380(2):434-41. - PMID 27400681 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.canlet.2019.03.031 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM29551888X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM29551888X | ||
003 | DE-627 | ||
005 | 20231225083835.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.canlet.2019.03.031 |2 doi | |
028 | 5 | 2 | |a pubmed24n0985.xml |
035 | |a (DE-627)NLM29551888X | ||
035 | |a (NLM)30929811 | ||
035 | |a (PII)S0304-3835(19)30187-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Gu, Jiangning |e verfasserin |4 aut | |
245 | 1 | 0 | |a Corrigendum to "GFRα2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer" [Cancer Lett. 380 (2) (2016 Oct 1) 434-41 |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.11.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a ErratumFor: Cancer Lett. 2016 Oct 1;380(2):434-41. - PMID 27400681 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
650 | 4 | |a Published Erratum | |
700 | 1 | |a Wang, Di |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jiaqiang |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Yi |e verfasserin |4 aut | |
700 | 1 | |a Li, Ying |e verfasserin |4 aut | |
700 | 1 | |a Chen, Hao |e verfasserin |4 aut | |
700 | 1 | |a Shi, Minmin |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xuelong |e verfasserin |4 aut | |
700 | 1 | |a Shen, Baiyong |e verfasserin |4 aut | |
700 | 1 | |a Deng, Xiaxing |e verfasserin |4 aut | |
700 | 1 | |a Zhan, Qian |e verfasserin |4 aut | |
700 | 1 | |a Wei, Gang |e verfasserin |4 aut | |
700 | 1 | |a Peng, Chenghong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer letters |d 1976 |g 452(2019) vom: 28. Juni, Seite 270 |w (DE-627)NLM000147273 |x 1872-7980 |7 nnns |
773 | 1 | 8 | |g volume:452 |g year:2019 |g day:28 |g month:06 |g pages:270 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.canlet.2019.03.031 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 452 |j 2019 |b 28 |c 06 |h 270 |